Format
Sort by

Send to

Choose Destination

Search results

Items: 2

2.

Intralesional lymphokine-activated killer cells as adjuvant therapy for primary glioblastoma.

Dillman RO, Duma CM, Ellis RA, Cornforth AN, Schiltz PM, Sharp SL, DePriest MC.

J Immunother. 2009 Nov-Dec;32(9):914-9. doi: 10.1097/CJI.0b013e3181b2910f.

PMID:
19816190

Supplemental Content

Loading ...
Support Center